3 568

Cited 0 times in

Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients.

Authors
 Joon Ho Moon  ;  Sang Kyun Sohn  ;  Shi Nae Kim  ;  Seon Yang Park  ;  Sung Soo Yoon  ;  In ho Kim  ;  Hyeoung Joon Kim  ;  Yeo Kyeoung Kim  ;  Yoo Hong Min  ;  June Won Cheong  ;  Jin Seok Kim  ;  Chul Won Jung  ;  Dong Hwan Kim 
Citation
 MEDICAL ONCOLOGY, Vol.29(2) : 1179-1185, 2012 
Journal Title
MEDICAL ONCOLOGY
ISSN
 1357-0560 
Issue Date
2012
MeSH
Adolescent ; Adult ; Aged ; Antineoplastic Agents/therapeutic use* ; Benzamides ; Child ; Counseling* ; Cross-Sectional Studies ; Female ; Follow-Up Studies ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy* ; Male ; Middle Aged ; Patient Compliance/statistics & numerical data* ; Patient Education as Topic* ; Piperazines/therapeutic use* ; Prognosis ; Program Evaluation ; Pyrimidines/therapeutic use* ; Republic of Korea ; Retrospective Studies ; Treatment Outcome ; Young Adult
Keywords
Chronic myeloid leukemia ; Compliance ; Imatinib ; Patient counseling program ; Persistence
Abstract
To achieve successful therapeutic outcomes in chronic myeloid leukemia (CML), continuous and adequate imatinib (Gleevec(®), Glivec(®), Novartis Pharmaceuticals, Basel, Switzerland) dosing is essential. Here, we report a patient counseling program ("Care club", "Happy club" in Korea) performed to improve patient compliance with imatinib. From January 2006 to December 2008, patients diagnosed with chronic phase CML and taking imatinb were eligible for this retrospective study. A total of 114 patients from 4 centers in Korea were recruited at a 50:50 ratio for Happy club group versus non-Happy club group at each center. During 36-month follow-up, persistency (the number of days of imatinib prescribed versus 1 year) was higher in the Happy club group (98.2 ± 0.03%) than in the non-Happy club group (79.3 ± 0.16%, P = 0.001), whereas dose compliance (miligrams of imatinib that were actually taken versus miligrams that should have been taken) was not different between two groups; 96.5 ± 0.6% and 96.6 ± 0.7% in the Happy club and non-Happy club (P = 0.958). Overall compliance (the product of persistency and dose compliance) improved in the Happy club group (93.0 ± 2.3%) compared with the non-Happy club group (76.2 ± 7.4%, P = 0.001). The patient counseling program was efficient especially in patients who needed high-dose imatinib (>400 mg/day), and overall compliance was 87.8 ± 6.0% in the Happy club group versus 65.5 ± 16.1% in the non-Happy club group (P = 0.017). In conclusion, the patient counseling program was effective in persisting imatinib medication, resulting in the improvement of overall compliance.
Full Text
http://link.springer.com/article/10.1007%2Fs12032-011-9926-8
DOI
21472487
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Jin Seok(김진석) ORCID logo https://orcid.org/0000-0001-8986-8436
Min, Yoo Hong(민유홍) ORCID logo https://orcid.org/0000-0001-8542-9583
Cheong, June-Won(정준원) ORCID logo https://orcid.org/0000-0002-1744-0921
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/91443
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links